诊断实验室自动化/监控解决方案的成长机会

Diagnostics Lab Automation and Monitoring Solutions Growth Opportunities

出版日期: 2024年06月17日 | 出版商:

Frost & Sullivan | 英文 60 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

自动化和数数位资料交换的交叉为诊断实验室释放了价值

病理学劳动力短缺、准确性问题以及价格和资源分配不均是诊断行业持续面临的挑战。

实验室检测结果是您未来健康的基础，影响 70% 的临床决策。人口老化、非传染性疾病、早发性癌症、第2型糖尿病以及其他心臟代谢和神经退化性疾病等持续趋势预计将导致每年的实验室检查数量迅速增加。

因此，数位技术的进步正在稳步扩大诊断实验室工具的使用范围，超越传统的医疗环境。消费者各个数位接触点的全通路体验的激增、行动应用程式、线上聚合平台的兴起以及自我护理趋势（例如预防性筛检）正在推动病理实验室数位使用者数量与前一年同期比较。某些技术，例如次世代定序，正在塑造高端专业测试的范围，包括肿瘤学、产前诊断和感染疾病诊断。

在这种背景下，对于希望拓展新市场的病理实验室来说，制定可靠的扩大策略来推动成长，同时提高弹性和永续性至关重要。许多实验室正在与体外诊断供应商合作，以扩大存取范围、优化网路组织并恢復实验室生产力。这些努力正在改善测试结果的交付，并创建一个在整个经济週期中持续的更相关的测试选单。

此外，策略性地利用数位化和自动化可以帮助实验室根据不断变化的消费者期望进行调整和发展，包括提高便利性、可负担性和更快的周转时间至关重要。然而，对遗留设备和工作流程的逐步升级可能会影响数位转型的成熟度。可以执行智慧操作的机器人自动化和主动实验室监控也正在进入该领域。实验室自动化/监测解决方案产业的复合年增长率预计为 9.1%，是诊断行业的关键曲折点。

Lab test results are the foundation of future human health, influencing 70% of clinical decisions. A surge in lab tests' yearly volume will result from persistent trends, including aging populations, growing non-communicable diseases, early-onset cancers, type 2 diabetes, and other cardiometabolic and neurodegenerative diseases.

In consequence, advancements in digital technology are steadily expanding the availability of lab diagnostic tools beyond traditional medical settings. The popularity of omnichannel experiences across various consumer digital touchpoints and the rise of mobile apps, online aggregator platforms, and self-care trends (for instance, preventive checks) are boosting the year-over-year (YoY) number of digital users of pathology labs. Certain technologies, such as next-generation sequencing, are shaping the high-end specialized test spectrum, including oncology, prenatal, and infectious disease diagnostics.

In this context, a robust business expansion strategy that drives growth while also improving resilience and sustainability is critical for pathology labs looking to expand their business to new markets. Many labs have partnered with in vitro diagnostics vendors to increase access, optimize network organization, and recover lab productivity. These efforts improve test results' delivery and generate better-oriented test menus that persist throughout economic cycles.

Furthermore, the strategic use of digitization and automation is vital for labs to pivot and grow with changing consumer expectations-improved convenience, affordable pricing, and quicker turnaround times. However, incremental upgrades to legacy equipment and workflows may affect digital transformation maturity. Robotic automation and proactive lab monitoring capable of performing intelligent operations are also entering the sector. With a projected 9.1% CAGR, the lab automation and monitoring solutions industry is a significant inflection point in the diagnostics industry.

Strategic Imperatives

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Lab Automation and Monitoring Solutions Industry
Growth Opportunities Fuel the Growth Pipeline Engine™